Healthy Controls Clinical Trial
Official title:
Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: "Proof of Concept" Study
The spread of the new SARS-CoV-2 virus has led to a pandemic. Described for the first time in China at the end of 2019, it causes Covid-19 disease. Its characteristics in terms of contagiousness and lethality have led countries to adapt their screening and care strategies. Early and accurate identification of people infected with SARs-CoV-2 is an essential measure to confront Covid-19 pandemic. A key aspect of Covid-19 is that diagnostic tests must be able to detect the virus in asymptomatic, pre-symptomatic and symptomatic patients. Changes in human odor, as symptoms of specific diseases, have been observed. Dogs have already been used to detect breast or lung cancer, diabetes, epilepsy or kidney disease with some success There is currently a growing body of research and previous work, though preliminary, indicating the possibility that dogs identify persons infected with Sars-Cov-2 compared to healthy persons. The purpose of this study is to determine whether trained detection dogs are able to identify asymptomatic patients infected by Sars-Cov-2. The investigators aim to validate the possibility to identify / discriminate patients with Covid-19 according to their odor by a proof of concept (with specificity and sensitivity of the detection test), i.e. new non-invasive screening method using dogs odor detection capabilities.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
| Recruiting |
NCT02572700 -
Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis
|
||
| Recruiting |
NCT01888783 -
Two Measures of Tactile Acuity in CRPS Type I Patients
|
N/A | |
| Recruiting |
NCT03741478 -
Intranasal Insulin and Olanzapine Study in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT02919774 -
Pomaglumetad Effects on Glutamate Biomarkers
|
Phase 1 | |
| Completed |
NCT01460394 -
Normative Data of Brain Network Activation in Adolescents and Young Adults
|
||
| Completed |
NCT00771940 -
Peripheral Metabolic Effects of Ghrelin
|
Phase 1 | |
| Recruiting |
NCT06068322 -
Supramaximal High-Intensity Interval Training in People With and Without Chronic Obstructive Pulmonary Disease
|
N/A | |
| Active, not recruiting |
NCT02652195 -
Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II
|
Phase 2 | |
| Recruiting |
NCT06270108 -
The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia
|
Early Phase 1 | |
| Withdrawn |
NCT04320966 -
Neurovascular Complications and White Matter Damage in Acquired Anemias
|
||
| Recruiting |
NCT05046184 -
Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets
|
Phase 2 | |
| Completed |
NCT03134963 -
Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study
|
||
| Completed |
NCT03081546 -
Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease
|
||
| Completed |
NCT04085094 -
Gender Differences in Renal Functioning and Disease
|
||
| Completed |
NCT03520543 -
[11C]Yohimbine PET Study of alpha2-AR
|
Phase 1 | |
| Recruiting |
NCT06098612 -
PET Imaging Evaluation of [11C]SY08
|
Early Phase 1 | |
| Completed |
NCT02134951 -
Biomarker Assessment of Glutamatergic Target Engagement
|
Phase 4 | |
| Active, not recruiting |
NCT05056610 -
Confocal Laser Endomicroscopy to Determine Influence of Food Antigens on Mucosal Integrity
|
N/A | |
| Recruiting |
NCT05656378 -
A Repository to Study Host-Microbiome Interactions in Health and Disease
|